Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study.

Renato PascaleZeno PasquiniMichele BartolettiLuca CaiazzoGiacomo FornaroLinda BussiniFrancesca VolpatoElisa MarchionniMatteo RinaldiFilippo TrapaniChiara TemperoniPaolo GaibaniSimone AmbrettiFrancesco BarchiesiPierluigi VialeMaddalena Giannella

Published in: JAC-antimicrobial resistance (2021)

Our study confirms the potential role of cefiderocol in the treatment of CR-Ab infection, but larger clinical studies are needed.

Keyphrases

acinetobacter baumannii
pseudomonas aeruginosa
randomized controlled trial
study protocol
risk assessment
cystic fibrosis
extracorporeal membrane oxygenation
replacement therapy
acute respiratory distress syndrome